# Nuoshan Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuoshan-technology

- Industry: Biotechnology
- Headquarters: Beijing, China
- Total disclosed funding: $1.4M
- Latest round: Angel (Mar 4, 2024)
- Investors on record: 1

## About

Based in Beijing, China, and founded in 2024, Nuoshan Technology operates as a biotechnology company that focuses on the development of microfluidic organic chips. The core team members are from Beijing Institute of Technology and Peking Union Medical College Hospital. In March 2024, it raised CNY 10 million in angel funding from new investor Tianjin Huakong Dianke Capital.

Nuoshan Technology specializes in preclinical research on microfluidic organic chips. The company has completed the development of a chip prototype and conducted a clinical cohort study of microfluidic chip-based cancer drug sensitivity testing at Peking Union Medical College Hospital. The microfluidic organics it developed can be used for lung cancer drug sensitivity testing.

## Funding rounds

- Angel, Mar 4, 2024, $1.4M — Tianjin Huakong Dianke Capital

## Investors

- Tianjin Huakong Dianke Capital (https://capitalatlas.ai/funds/tianjin-huakong-dianke-capital) — Angel